Coloplast A/S (CLPBF)

Market Cap	27.64B
Revenue (ttm)	4.04B
Net Income (ttm)	755.59M
Shares Out	n/a
EPS (ttm)	3.36
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	206
Open	126.00
Previous Close	124.60
Day's Range	123.00 - 126.00
52-Week Range	105.50 - 143.15
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2024

About Coloplast

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the B...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1954
• Employees: 16,639
• Stock Exchange: OTCMKTS
• Ticker Symbol: CLPBF

Financial Performance

In 2024, Coloplast's revenue was 27.03 billion, an increase of 10.33% compared to the previous year's 24.50 billion. Earnings were 5.05 billion, an increase of 5.62%.

Financial numbers in DKK